Clinical Trial Update: Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating nanocrystalline megestrol in malnourished patients with first-line non-small cell lung cancer. The trial status is NOT_YET_REC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nanocrystalline Megestrol (Megestrol acetate)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING